In AD patients, there is an additional marked increase in expression for the TLR2, TLR7, and CD14 (another LPS receptor) [24,161], further amplifying the effect of Aβ on glial activation via TLRs (Table 1). Here, TLR2 is linked to Alzheimer disease.